Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Methotrexate
•
General Rheumatology
•
Dermatology
•
Alopecia
What is your approach to diagnosing and managing methotrexate-induced alopecia?
What are the typical clinical patterns you observe?
Related Questions
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
What is the maximum dose of leucovorin that you use with methotrexate?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
When considering a biologic for seropositive RA after failure of methotrexate or triple therapy, do you consider using abatacept as a first line biologic or would prefer choosing TNFi?
What are your vaccine recommendations while patients are on biologics?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?